Genomic relatedness of a canine Lactococcus garvieae to human, animal and environmental isolates
Lactococcus (L.) garvieae is a zoonotic fish pathogen that may additionally trigger bacteraemia and endocarditis in people and has been remoted from wholesome or diseased home animals. Nonetheless L. garvieae is extra an opportunistic, than a main pathogen since most affected people have predisposing circumstances and comorbidities. L. garvieae can also be current in different animal species, most incessantly cattle, but in addition sheep, goats, water buffaloes, and pigs, and rather more hardly ever canine, cats, horses, camel, turtle, snake and crocodile.
The aim of this examine was to genomically (i) verify the identification by MALDI-TOF MS® of a L. garvieae from the nasal discharge of a canine with power respiratory problems and (ii) examine this canine isolate with human and animal L. garvieae isolates. In accordance with the BLAST evaluation after Complete Genome Sequencing, this canine isolate was greater than 99% an identical to three L. garvieae and belonged to a brand new Multi-Locus Sequence Sort (ST45). MLST and entire genomes-based phylogenetic evaluation have been carried out on the canine isolate and the 40 genomes out there in Genbank.
The canine L. garvieae was most carefully associated to an Australian camel and an Indian fish L. garvieae and extra distantly to human L. garvieae. Twenty-five of the 29 putative virulence-associated genes looked for have been detected, however not the 16 capsule-encoding genes. The heterogeneity of the L. garvieae species is mirrored by the variety of the MLSTypes and virulotypes recognized and by the phylogenetic evaluation.
Genomic Variety and Virulence Potential of ESBL- and AmpC-β-Lactamase-Producing Escherichia coli Strains From Wholesome Meals Animals Throughout Europe
The function of livestock animals as a putative supply of ESBL/pAmpC E. coli for people is a central subject of analysis. In a large-scale pan-European surveillance, 2,993 commensal Escherichia spp. isolates have been recovered from randomly collected fecal samples of wholesome cattle, pigs and chickens in varied abattoirs. One-hundred Escherichia spp. isolates (0.5% from cattle, 1.3% pigs, 8.0% chickens) fulfilled the standards for cefotaxime and ceftazidime non-wildtype (EUCAST). In silico screening of WGS knowledge of 99 isolates (98 E. coli and 1 E.
fergusonii) revealed bla SHV – 12 (32.3%), bla CTX – M – 1 (24.2%), and bla CMY – 2 (22.2%) as predominant ESBL/pAmpC varieties. Different varieties have been bla SHV – 2 (1.0%), bla CTX – M – 2 / – 14 / – 15 (1.0/6.1/1.0%), and bla TEM – 52 (5.1%). Six isolates revealed AmpC-promoter mutations (place -42 (C > T) and one carried mcr-1. The bulk (91.3%) of ESBL/pAmpC genes have been positioned on plasmids. SHV-12 was primarily (50%) encoded on IncI1α plasmids (pST-3/-26/-95), adopted by IncX3 (12.5%) and IncK2 (3.1%). The bla TEM – 52 genes have been positioned on IncI1α-pST-36 (60%) and IncX1 plasmids (20%).
The dominant plasmid lineage amongst CTX-M-1 isolates was IncI1α (pST-3/-295/-317) (87.5%), adopted by IncN-pST-1 (8.3%). CMY-2 was principally recognized on IncI1α (pST-12/-2) (54.5%) and IncK2 (31.8%) plasmids. A number of plasmids revealed excessive similarity to printed plasmids from human and animal Enterobacteriaceae. The isolates have been assigned to phylogroups A/C (34.7/7.1%), B1 (27.6%), B2 (3.1%), D/F (9.2/10.2%), E (5.1%), and to E. clades (3.0%).
With 51 identified and a couple of novel MLST varieties, all kinds of STs was discovered, together with STs beforehand noticed in human isolates (ST10/38/117/131/648). ESBL/AmpC varieties or STs have been hardly ever correlated with the geographic origin of the isolates or animal species. Virulence gene typing recognized extraintestinal pathogenic E. coli (ExPEC; 2.0%), avian pathogenic E. coli (APEC; 51.5%), and atypical enteropathogenic E. coli (EPEC; 6.1%).
In conclusion, the excessive range of STs and phylogenetic teams gives hardly any trace for clonal unfold of single lineages however hints towards the dissemination of cephalosporin resistance genes in livestock by way of distinct, globally profitable plasmid lineages. Though quite a lot of isolates couldn’t be assigned to a definite pathotype, our discovering of mixed multidrug-resistance and virulence on this facultative pathogen needs to be thought-about a further risk to public well being.
Excessive-resolution genomic comparisons inside Salmonella enterica serotypes derived from beef feedlot cattle: parsing the roles of cattle supply, pen, animal, pattern sort and manufacturing interval
Salmonella enterica is a significant foodborne pathogen, and contaminated beef merchandise have been recognized as one of many main sources of Salmonella-related outbreaks. Pathogenicity and antibiotic resistance of Salmonella are extremely serotype- and subpopulation-specific, which makes it important to know high-resolution Salmonella inhabitants dynamics in cattle. Time of yr, supply of cattle, pen, and pattern sort(i.e., feces, cover or lymph nodes) have beforehand been recognized as vital elements influencing the serotype distribution of Salmonella (e.g., Anatum, Lubbock, Cerro, Montevideo, Kentucky, Newport, and Norwich) that have been remoted from a longitudinal sampling design in a analysis feedlot.
On this examine, we carried out high-resolution genomic comparisons of Salmonella isolates inside every serotype utilizing each single-nucleotide polymorphism (SNP)-based most chance phylogeny and hierarchical clustering of core-genome multi-locus sequence typing. The significance of the aforementioned options on clonal Salmonella enlargement was additional explored utilizing a supervised machine studying algorithm. As well as, we recognized and in contrast the resistance genes, plasmids, and pathogenicity island profiles of the isolates inside every sub-population.
Our findings point out that clonal enlargement of Salmonella strains in cattle was primarily influenced by the randomization of block and pen, in addition to the origin/supply of the cattle; that’s, no matter sampling time and pattern sort (i.e., feces, lymph node or cover). Additional analysis is required in regards to the function of the feedlot pen atmosphere previous to cattle placement to higher perceive carry-over contributions of present strains of Salmonella and their bacteriophages.
IMPORTANCE Salmonella serotypes remoted from outbreaks in people will also be present in beef cattle and feedlots. Virulence elements and antibiotic resistance are among the many main protection mechanisms of Salmonella, and are sometimes related to clonal enlargement. This makes understanding the subpopulation dynamics of Salmonella in cattle essential for efficient mitigation. There stays a spot within the literature regarding subpopulation dynamics inside Salmonella serotypes in feedlot cattle from the start of feeding up till slaughter.
Recombinant Human Annexin A2 (ANXA2) |
|||
| CSB-EP001840HUe0 | Cusabio | 549 mg | Ask for price |
Recombinant Human Annexin A2 (ANXA2) |
|||
| CSB-MP001840HU | Cusabio | 4881 mg | Ask for price |
Recombinant Human Annexin A2 (ANXA2) |
|||
| RPC20900-100ug | Biomatik Corporation | 100ug | EUR 475.2 |
Recombinant Human Annexin A2 (ANXA2) |
|||
| RPC20900-1mg | Biomatik Corporation | 1mg | EUR 2411.5 |
Recombinant Human Annexin A2 (ANXA2) |
|||
| RPC20900-20ug | Biomatik Corporation | 20ug | EUR 295.7 |
Recombinant Human Annexin A2 (ANXA2) |
|||
| RPC25841-100ug | Biomatik Corporation | 100ug | EUR 585.2 |
Recombinant Human Annexin A2 (ANXA2) |
|||
| RPC25841-1mg | Biomatik Corporation | 1mg | EUR 2706.6 |
Recombinant Human Annexin A2 (ANXA2) |
|||
| RPC25841-20ug | Biomatik Corporation | 20ug | EUR 295.7 |
Recombinant Human Annexin A2 (ANXA2) |
|||
| RPC23807-100ug | Biomatik Corporation | 100ug | EUR 1503.7 |
Recombinant Human Annexin A2 (ANXA2) |
|||
| RPC23807-20ug | Biomatik Corporation | 20ug | EUR 484 |
Recombinant Human Annexin A2 (ANXA2) |
|||
| MBS968326-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 275 |
Recombinant Human Annexin A2 (ANXA2) |
|||
| MBS968326-002mgMammalianCell | MyBiosource | 0.02mg(Mammalian-Cell) | EUR 425 |
Recombinant Human Annexin A2 (ANXA2) |
|||
| MBS968326-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1000 |
Recombinant Human Annexin A2 (ANXA2) |
|||
| MBS968326-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 460 |
Recombinant Human Annexin A2 (ANXA2) |
|||
| MBS968326-01mgMammalianCell | MyBiosource | 0.1mg(Mammalian-Cell) | EUR 1015 |
Recombinant Human Annexin A2/ANXA2 Protein |
|||
| PKSH032074-10ug | Elabscience Biotech | 10ug | EUR 129 |
|
Description: Human |
|||
Recombinant Human Annexin A2/ANXA2 Protein |
|||
| PKSH032074-50ug | Elabscience Biotech | 50ug | EUR 375 |
|
Description: Human |
|||
Recombinant Human Annexin A2/ANXA2 Protein |
|||
| MBS2552354-001mg | MyBiosource | 0.01mg | EUR 180 |
Recombinant Human Annexin A2/ANXA2 Protein |
|||
| MBS2552354-005mg | MyBiosource | 0.05mg | EUR 380 |
Recombinant Human Annexin A2/ANXA2 Protein |
|||
| MBS2552354-5x005mg | MyBiosource | 5x0.05mg | EUR 1690 |
Recombinant Annexin A2 (ANXA2) |
|||
| RPU57039-100ug | Biomatik Corporation | 100ug | EUR 470.4 |
Recombinant Annexin A2 (ANXA2) |
|||
| RPU57039-1mg | Biomatik Corporation | 1mg | EUR 2184 |
Recombinant Annexin A2 (ANXA2) |
|||
| RPU57039-50ug | Biomatik Corporation | 50ug | EUR 385 |
Recombinant Annexin A2 (ANXA2) |
|||
| RPU55312-100ug | Biomatik Corporation | 100ug | EUR 431.2 |
Recombinant Annexin A2 (ANXA2) |
|||
| RPU55312-1mg | Biomatik Corporation | 1mg | EUR 1911 |
Recombinant Annexin A2 (ANXA2) |
|||
| RPU55312-50ug | Biomatik Corporation | 50ug | EUR 346.5 |
Recombinant Annexin A2 (ANXA2) |
|||
| RPU52100-100ug | Biomatik Corporation | 100ug | EUR 517 |
Recombinant Annexin A2 (ANXA2) |
|||
| RPU52100-1mg | Biomatik Corporation | 1mg | EUR 2293.2 |
Recombinant Annexin A2 (ANXA2) |
|||
| RPU52100-50ug | Biomatik Corporation | 50ug | EUR 415.8 |
Recombinant Annexin A2 (ANXA2) |
|||
| RPB944Hu01 | Cloud-Clone | 10ug | EUR 152 |
Recombinant Annexin A2 (ANXA2) |
|||
| 4-RPB944Hu01 | Cloud-Clone |
|
|
|
Description: Recombinant Human Annexin A2 expressed in: E.coli |
|||
Recombinant Annexin A2 (ANXA2) |
|||
| RPB944Hu03 | Cloud-Clone | 10ug | EUR 154 |
Recombinant Annexin A2 (ANXA2) |
|||
| RPB944Hu04 | Cloud-Clone | 10ug | EUR 154 |
Recombinant Annexin A2 (ANXA2) |
|||
| RPB944Mu01 | Cloud-Clone | 10ug | EUR 168 |
Recombinant Annexin A2 (ANXA2) |
|||
| 4-RPB944Mu01 | Cloud-Clone |
|
|
|
Description: Recombinant Mouse Annexin A2 expressed in: E.coli |
|||
Recombinant Annexin A2 (ANXA2) |
|||
| RPB944Mu02 | Cloud-Clone | 10ug | EUR 140 |
Recombinant Annexin A2 (ANXA2) |
|||
| RPB944Ra01 | Cloud-Clone | 10ug | EUR 140 |
Recombinant Annexin A2 (ANXA2) |
|||
| 4-RPB944Ra01 | Cloud-Clone |
|
|
|
Description: Recombinant Rat Annexin A2 expressed in: E.coli |
|||
Recombinant Annexin A2 (ANXA2) |
|||
| RPU40298-100ug | Biomatik Corporation | 100ug | EUR 468.6 |
Recombinant Annexin A2 (ANXA2) |
|||
| RPU40298-1mg | Biomatik Corporation | 1mg | EUR 2074.8 |
Recombinant Annexin A2 (ANXA2) |
|||
| RPU40298-50ug | Biomatik Corporation | 50ug | EUR 376.2 |
Recombinant Annexin A2 (ANXA2) |
|||
| MBS2030860-001mg | MyBiosource | 0.01mg | EUR 170 |
Recombinant Annexin A2 (ANXA2) |
|||
| MBS2030860-005mg | MyBiosource | 0.05mg | EUR 295 |
Recombinant Annexin A2 (ANXA2) |
|||
| MBS2030860-01mg | MyBiosource | 0.1mg | EUR 445 |
Recombinant Annexin A2 (ANXA2) |
|||
| MBS2030860-02mg | MyBiosource | 0.2mg | EUR 540 |
Recombinant Annexin A2 (ANXA2) |
|||
| MBS2030860-05mg | MyBiosource | 0.5mg | EUR 1025 |
Recombinant Annexin A2 (ANXA2) |
|||
| MBS2097690-001mg | MyBiosource | 0.01mg | EUR 155 |
Recombinant Annexin A2 (ANXA2) |
|||
| MBS2097690-005mg | MyBiosource | 0.05mg | EUR 260 |
Recombinant Annexin A2 (ANXA2) |
|||
| MBS2097690-01mg | MyBiosource | 0.1mg | EUR 375 |
Recombinant Annexin A2 (ANXA2) |
|||
| MBS2097690-02mg | MyBiosource | 0.2mg | EUR 460 |
Recombinant Annexin A2 (ANXA2) |
|||
| MBS2097690-05mg | MyBiosource | 0.5mg | EUR 860 |
Recombinant Annexin A2 (ANXA2) |
|||
| MBS2009095-001mg | MyBiosource | 0.01mg | EUR 160 |
Recombinant Annexin A2 (ANXA2) |
|||
| MBS2009095-005mg | MyBiosource | 0.05mg | EUR 280 |
Recombinant Annexin A2 (ANXA2) |
|||
| MBS2009095-01mg | MyBiosource | 0.1mg | EUR 405 |
Recombinant Annexin A2 (ANXA2) |
|||
| MBS2009095-02mg | MyBiosource | 0.2mg | EUR 490 |
Recombinant Annexin A2 (ANXA2) |
|||
| MBS2009095-05mg | MyBiosource | 0.5mg | EUR 930 |
ANXA2 Annexin A2 Human Recombinant Protein |
|||
| PROTP07355 | BosterBio | Regular: 20ug | EUR 380.4 |
|
Description: ANXA2 Human Recombinant produced in E.Coli is a single, non-glycosylated,_x000D_ polypeptide chain containing 376 amino acids (1-339a.a.) and having a molecular mass of 42.8 kDa. ANXA2 is fused to a 37 amino acid His-Tag at N-Terminus and purified by proprietary chromatographic techniques._x000D_ |
|||
Human ANXA2 (Annexin A2) Recombinant Protein |
|||
| MBS698047-005mg | MyBiosource | 0.05mg | EUR 580 |
Human ANXA2 (Annexin A2) Recombinant Protein |
|||
| MBS698047-02mg | MyBiosource | 0.2mg | EUR 1290 |
Human ANXA2 (Annexin A2) Recombinant Protein |
|||
| MBS698047-05mg | MyBiosource | 0.5mg | EUR 2350 |
Human ANXA2 (Annexin A2) Recombinant Protein |
|||
| MBS698047-1mg | MyBiosource | 1mg | EUR 3585 |
Recombinant Dog Annexin A2 (ANXA2) |
|||
| MBS1482145-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1215 |
Recombinant Dog Annexin A2 (ANXA2) |
|||
| MBS1482145-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 870 |
Recombinant Dog Annexin A2 (ANXA2) |
|||
| MBS1482145-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1005 |
Recombinant Dog Annexin A2 (ANXA2) |
|||
| MBS1482145-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1045 |
Recombinant Dog Annexin A2 (ANXA2) |
|||
| MBS1482145-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1145 |
Recombinant Pig Annexin A2 (ANXA2) |
|||
| MBS958396-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1215 |
Recombinant Pig Annexin A2 (ANXA2) |
|||
| MBS958396-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 870 |
Recombinant Pig Annexin A2 (ANXA2) |
|||
| MBS958396-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1005 |
Recombinant Pig Annexin A2 (ANXA2) |
|||
| MBS958396-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1045 |
Recombinant Pig Annexin A2 (ANXA2) |
|||
| MBS958396-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1145 |
Recombinant Human Annexin A2/ANXA2 Protein, No Tag |
|||
| E40KMH669 | EnoGene | 20ug | EUR 495 |
Recombinant Mouse Annexin A2 (Anxa2) |
|||
| CSB-YP001840MO | Cusabio | 10552 mg | Ask for price |
Recombinant Mouse Annexin A2 (Anxa2) |
|||
| CSB-EP001840MO | Cusabio | 10290 mg | Ask for price |
Recombinant Mouse Annexin A2 (Anxa2) |
|||
| CSB-MP001840MO | Cusabio | 10172 mg | Ask for price |
Recombinant Sheep Annexin A2 (ANXA2) |
|||
| MBS1147005-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1215 |
Recombinant Sheep Annexin A2 (ANXA2) |
|||
| MBS1147005-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 870 |
Recombinant Sheep Annexin A2 (ANXA2) |
|||
| MBS1147005-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1005 |
Recombinant Sheep Annexin A2 (ANXA2) |
|||
| MBS1147005-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1045 |
Recombinant Sheep Annexin A2 (ANXA2) |
|||
| MBS1147005-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1145 |
Recombinant Mouse Annexin A2 (Anxa2) |
|||
| MBS950991-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1210 |
Recombinant Mouse Annexin A2 (Anxa2) |
|||
| MBS950991-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 865 |
Recombinant Mouse Annexin A2 (Anxa2) |
|||
| MBS950991-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1000 |
Recombinant Mouse Annexin A2 (Anxa2) |
|||
| MBS950991-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1040 |
Recombinant Mouse Annexin A2 (Anxa2) |
|||
| MBS950991-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Bovine Annexin A2 (ANXA2) |
|||
| MBS954139-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1215 |
Recombinant Bovine Annexin A2 (ANXA2) |
|||
| MBS954139-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 870 |
Recombinant Bovine Annexin A2 (ANXA2) |
|||
| MBS954139-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1005 |
Recombinant Bovine Annexin A2 (ANXA2) |
|||
| MBS954139-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1045 |
Recombinant Bovine Annexin A2 (ANXA2) |
|||
| MBS954139-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1145 |
Recombinant Chicken Annexin A2 (ANXA2) |
|||
| MBS951249-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1215 |
Recombinant Chicken Annexin A2 (ANXA2) |
|||
| MBS951249-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 870 |
Recombinant Chicken Annexin A2 (ANXA2) |
|||
| MBS951249-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1005 |
Recombinant Chicken Annexin A2 (ANXA2) |
|||
| MBS951249-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1045 |
Recombinant Chicken Annexin A2 (ANXA2) |
|||
| MBS951249-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1145 |
Recombinant Pongo abelii Annexin A2 (ANXA2) |
|||
| MBS1308108-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1215 |
Recombinant Pongo abelii Annexin A2 (ANXA2) |
|||
| MBS1308108-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 870 |
Recombinant Pongo abelii Annexin A2 (ANXA2) |
|||
| MBS1308108-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1005 |
Recombinant Pongo abelii Annexin A2 (ANXA2) |
|||
| MBS1308108-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1045 |
Recombinant Pongo abelii Annexin A2 (ANXA2) |
|||
| MBS1308108-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1145 |
Human Annexin A2 (ANXA2) |
|||
| 1-CSB-EP001840HU | Cusabio |
|
|
|
Description: Recombinant Human Annexin A2(ANXA2) expressed in E.coli |
|||
Human Annexin A2 (ANXA2) |
|||
| 1-CSB-EP001840HUa0 | Cusabio |
|
|
|
Description: Recombinant Human Annexin A2(ANXA2) expressed in E.coli |
|||
Human Annexin A2 (ANXA2) |
|||
| 1-CSB-EP001840HUb2 | Cusabio |
|
|
|
Description: Recombinant Human Annexin A2(ANXA2) expressed in E.coli |
|||
Human Annexin A2 (ANXA2) |
|||
| 1-CSB-EP001840HUe0 | Cusabio |
|
|
|
Description: Recombinant Human Annexin A2(ANXA2) expressed in E.coli |
|||
Human Annexin A2 (ANXA2) |
|||
| 1-CSB-MP001840HU | Cusabio |
|
|
|
Description: Recombinant Human Annexin A2(ANXA2) expressed in Mammalian cell |
|||
Recombinant Cervus elaphus Annexin A2 (ANXA2) |
|||
| MBS1334880-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1215 |
Recombinant Cervus elaphus Annexin A2 (ANXA2) |
|||
| MBS1334880-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 870 |
Recombinant Cervus elaphus Annexin A2 (ANXA2) |
|||
| MBS1334880-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1005 |
Recombinant Cervus elaphus Annexin A2 (ANXA2) |
|||
| MBS1334880-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1045 |
Recombinant Cervus elaphus Annexin A2 (ANXA2) |
|||
| MBS1334880-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1145 |
Human Annexin A2 (ANXA2) Protein |
|||
| 20-abx065365 | Abbexa |
|
|
Human Annexin A2 (ANXA2) Protein |
|||
| abx065365-100g | Abbexa | 100 µg | EUR 512.5 |
Human Annexin A2 (ANXA2) Protein |
|||
| abx065365-10g | Abbexa | 10 µg | EUR 212.5 |
Human Annexin A2 (ANXA2) Protein |
|||
| abx065365-50g | Abbexa | 50 µg | EUR 362.5 |
Human Annexin A2 (ANXA2) Protein |
|||
| abx263373-1mg | Abbexa | 1 mg | EUR 225 |
Human Annexin A2 (ANXA2) Protein |
|||
| abx263373-25mg | Abbexa | 2.5 mg | EUR 325 |
Human Annexin A2 (ANXA2) Protein |
|||
| abx260570-10g | Abbexa | 10 µg | EUR 325 |
Human Annexin A2 (ANXA2) Protein |
|||
| abx260570-2g | Abbexa | 2 µg | EUR 225 |
Annexin A2/ANXA2 |
|||
| E21-205 | EnoGene | 10ug | EUR 225 |
|
Description: Recombinant Human Annexin A2 is produced by our E.coli expression system and the target gene encoding Ser2-Asp339 is expressed. |
|||
Annexin A2/ANXA2 |
|||
| MBS8532871-001mg | MyBiosource | 0.01mg | EUR 305 |
Annexin A2/ANXA2 |
|||
| MBS8532871-5x001mg | MyBiosource | 5x0.01mg | EUR 1220 |
Human Annexin A2 (ANXA2) CLIA Kit |
|||
| 20-abx190397 | Abbexa |
|
|
Human Annexin A2 (ANXA2) CLIA Kit |
|||
| abx195131-96tests | Abbexa | 96 tests | EUR 990 |
Human Annexin A2 (ANXA2) CLIA Kit |
|||
| EKN51138-48T | Biomatik Corporation | 48T | EUR 414.89 |
Human Annexin A2 (ANXA2) CLIA Kit |
|||
| EKN51138-5x96T | Biomatik Corporation | 5x96T | EUR 2815.33 |
Human Annexin A2 (ANXA2) CLIA Kit |
|||
| EKN51138-96T | Biomatik Corporation | 96T | EUR 592.7 |
Human Annexin A2 (ANXA2) CLIA Kit |
|||
| EKU10027-48T | Biomatik Corporation | 48T | EUR 666.82 |
Human Annexin A2 (ANXA2) CLIA Kit |
|||
| EKU10027-5x96T | Biomatik Corporation | 5x96T | EUR 4524.85 |
Human Annexin A2 (ANXA2) CLIA Kit |
|||
| EKU10027-96T | Biomatik Corporation | 96T | EUR 952.6 |
Human Annexin A2 (ANXA2)CLIA Kit |
|||
| SCB944Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | EUR 6777.36 |
|
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Annexin A2 (ANXA2) in serum, plasma and other biological fluids. |
|||
Human Annexin A2 (ANXA2)CLIA Kit |
|||
| SCB944Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | EUR 663.31 |
|
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Annexin A2 (ANXA2) in serum, plasma and other biological fluids. |
|||
Human Annexin A2 (ANXA2)CLIA Kit |
|||
| SCB944Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | EUR 896.16 |
|
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Annexin A2 (ANXA2) in serum, plasma and other biological fluids. |
|||
Human Annexin A2 (ANXA2)CLIA Kit |
|||
| SCB944Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | EUR 3672.72 |
|
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Annexin A2 (ANXA2) in serum, plasma and other biological fluids. |
|||
Human Annexin A2 (ANXA2) CLIA Kit |
|||
| 4-SCB944Hu | Cloud-Clone |
|
|
|
Description: Double-antibody Sandwich chemiluminescent immunoassay for detection of Human Annexin A2 (ANXA2)Serum, plasma and other biological fluids |
|||
Human Annexin A2 (ANXA2) CLIA Kit |
|||
| MBS2000892-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 6205 |
Human Annexin A2 (ANXA2) CLIA Kit |
|||
| MBS2000892-24StripWells | MyBiosource | 24-Strip-Wells | EUR 405 |
Human Annexin A2 (ANXA2) CLIA Kit |
|||
| MBS2000892-48StripWells | MyBiosource | 48-Strip-Wells | EUR 625 |
Human Annexin A2 (ANXA2) CLIA Kit |
|||
| MBS2000892-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 3400 |
Human Annexin A2 (ANXA2) CLIA Kit |
|||
| MBS2000892-96StripWells | MyBiosource | 96-Strip-Wells | EUR 845 |
Human Annexin A2 (ANXA2) CLIA Kit |
|||
| MBS2709004-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3735 |
Human Annexin A2 (ANXA2) CLIA Kit |
|||
| MBS2709004-24StripWells | MyBiosource | 24-Strip-Wells | EUR 275 |
Human Annexin A2 (ANXA2) CLIA Kit |
|||
| MBS2709004-48StripWells | MyBiosource | 48-Strip-Wells | EUR 365 |
Human Annexin A2 (ANXA2) CLIA Kit |
|||
| MBS2709004-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 1935 |
Human Annexin A2 (ANXA2) CLIA Kit |
|||
| MBS2709004-96StripWells | MyBiosource | 96-Strip-Wells | EUR 480 |
ANXA2 Annexin A2 Human protein |
|||
| PROTP07355-1 | BosterBio | Regular: 5ug | EUR 380.4 |
|
Description: The Human Annexin A2 produced from Human Adipose Tissue has a molecular mass of 38.472kDa (calculated without glycosylation) containing 338 amino acid residues. |
|||
Human Annexin A2 (ANXA2) ELISA Kit |
|||
| 20-abx150668 | Abbexa |
|
|
Human Annexin A2 (ANXA2) ELISA Kit |
|||
| abx251337-96tests | Abbexa | 96 tests | EUR 801.6 |
Human Annexin A2 (ANXA2) ELISA Kit |
|||
| abx573296-96tests | Abbexa | 96 tests | EUR 801.6 |
Human Annexin A2 (ANXA2) ELISA Kit |
|||
| DLR-ANXA2-Hu | DL Develop | 96T | EUR 443 |
|
Description: serum, plasma, tissue homogenates or other biological fluids. |
|||
Human Annexin A2 (ANXA2) ELISA Kit |
|||
| DLR-ANXA2-Hu-48T | DL Develop | 48T | EUR 597.6 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Annexin A2 (ANXA2) in samples from serum, plasma, tissue homogenates or other biological fluids. |
|||
Human Annexin A2 (ANXA2) ELISA Kit |
|||
| DLR-ANXA2-Hu-96T | DL Develop | 96T | EUR 776.4 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Annexin A2 (ANXA2) in samples from serum, plasma, tissue homogenates or other biological fluids. |
|||
Human Annexin A2 (ANXA2) ELISA Kit |
|||
| EKN43538-48T | Biomatik Corporation | 48T | EUR 359.87 |
Human Annexin A2 (ANXA2) ELISA Kit |
|||
| EKN43538-5x96T | Biomatik Corporation | 5x96T | EUR 2441.98 |
Human Annexin A2 (ANXA2) ELISA Kit |
|||
| EKN43538-96T | Biomatik Corporation | 96T | EUR 514.1 |
Human Annexin A2 (ANXA2) ELISA Kit |
|||
| EKU02427-48T | Biomatik Corporation | 48T | EUR 527.66 |
Human Annexin A2 (ANXA2) ELISA Kit |
|||
| EKU02427-5x96T | Biomatik Corporation | 5x96T | EUR 3580.55 |
Right here, we discover Salmonella inhabitants dynamics inside every serotype utilizing core genome phylogeny and hierarchical classifications. We used machine-learning to quantitatively parse the relative significance of each hierarchical and longitudinal clustering amongst cattle host samples. Our outcomes reveal that Salmonella populations in cattle are extremely clonal over a 6-month examine interval, and that clonal dissemination of Salmonella in cattle is especially influenced spatially by experimental block and pen, as nicely by the geographical origin of the cattle.
